Medication-overuse headache in patients with cluster headache

@article{Paemeleire2006MedicationoveruseHI,
  title={Medication-overuse headache in patients with cluster headache},
  author={Koen Paemeleire and Anish Bahra and Stefan Evers and Manjit Singh Matharu and Peter J. Goadsby},
  journal={Neurology},
  year={2006},
  volume={67},
  pages={109 - 113}
}
Objective: Medication-overuse headache (MOH) in cluster headache (CH) patients is incompletely described, perhaps because of the relatively low prevalence of CH. Methods: The authors describe a retrospective series of 17 patients (13 men, 4 women) with CH who developed MOH in association with overuse of a wide range of monotherapies or varying combinations of simple analgesics (n = 9), caffeine (n = 1), opioids (n = 10), ergotamine (n = 3), and triptans (n = 14). The series includes both… Expand
Management of medication overuse headache.
TLDR
It is shown that MOH is most likely to affect patients with migraine and/or tension-type headache, but can also arise in association with cluster headache, particularly if there is a personal or family history of migraine or regular headache. Expand
Medication-overuse headache: risk factors, pathophysiology and management
TLDR
In all patients with MOH, relapse rates can be reduced by patient education and care in the follow-up period, and the success rate of treatment is around 50–70%, although patients whose MOH is associated with opioid overuse have higher relapse rates. Expand
Medication-overuse headache in patients with cluster headache
TLDR
Patients with CH, especially those with a personal and/or family history of migraine, must be carefully monitored for MOH, and medication withdrawal should be considered if a CH patient presents with features of MOH. Expand
Clinical features, pathophysiology, and treatment of medication-overuse headache
TLDR
As MOH can severely affect the quality of life of patients, it needs to be recognised early to enable appropriate treatment to be initiated and there is no clear evidence on which method of withdrawal therapy is the most efficacious. Expand
Medication-overuse headache: a review
TLDR
It is suggested that information and education about the risk of MOH is important since the condition is preventable and treatable, and patients suffering with MOH have much to gain by an earlier treatment-focused approach. Expand
Medication Overuse Headache: Causes, Consequences, and Treatment
TLDR
It is encouraging that several clinical and experimental advances have shed new light on the neuropharmacology of nociception and have prompted new hope for more effective treatments of such diverse problems as chronic headache pain, migraine, and drug dependency. Expand
Medication Overuse Headache
TLDR
The mainstay of MOH treatment is not only to detoxify the patients and to stop the chronic headache but also, most likely, to improve responsiveness to acute or prophylactic drugs. Expand
Headache attributed to a substance or its withdrawal.
TLDR
The only strategy to reduce the prevalence of M OH is to prevent the development of MOH in the first place by clear restriction of monthly doses of antiheadache drugs and constant education of both patients and physicians prescribing or recommending anti headache drugs. Expand
Management of medication-overuse headache
TLDR
Medication-overuse headache has developed into the third most common type of headache after tension-type headache and migraine and shows an increasing trend. Expand
Management of Cluster Headache
TLDR
The relatively short-lasting attack of pain in one eye with typical associated symptoms should lead the family doctor to suspect cluster headache resulting in a referral to a neurologist or a headache centre with experience in the treatment of cluster headache. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 84 REFERENCES
Probable medication-overuse headache
TLDR
The benefit of withdrawal in already established medication overuse is demonstrated and the existence of medication-overuse headache as a clinical entity is supported. Expand
Cluster headache: A prospective clinical study with diagnostic implications
TLDR
Patients with cluster headache offer a population of primary headache patients with devastating acute attacks of pain and the syndrome is stereotyped with effective evidence-based treatments that are prescribed in only half of patients having cluster headache. Expand
Medication overuse headaches – what is new?
TLDR
In view of the high prevalence and relapse rate, it is necessary to establish a structured post-treatment programme for patients after the acute withdrawal phase, which considers the predictors for relapse. Expand
Practical management of medication-overuse headache.
Epidemiological studies suggest that medication-overuse as defined by the International Headache Society is extremely common in patients with chronic daily headache. If all medication-overuseExpand
The clinical characteristics of headache in patients with pituitary tumours.
TLDR
Headache appears to be a significant problem in pituitary disease and is associated with a range of headache phenotypes, likely to be governed by a combination of factors, including tumour activity, relationship to the cavernous sinus and patient predisposition to headache. Expand
Features of medication overuse headache following overuse of different acute headache drugs
TLDR
Although patients overusing ergots and analgesics typically had a daily tension-type headache, patients with triptan-induced MOH were more likely to describe a (daily) migrainelike headache or an increase in migraine frequency. Expand
Medication-overuse headache: a worldwide problem
TLDR
The new international classification of headache disorders has now incorporated additional criteria and new headache entities that will facilitate the diagnosis of MOH. Expand
Features involved in the diagnostic delay of cluster headache
TLDR
Cluster headache remains unrecognised or misdiagnosed in many cases for many years, and should be recognised as part of the clinical spectrum of CH. Expand
Cluster headache with aura
TLDR
The frequency and characteristics of cluster headaches with aura among the population of patients with cluster headache treated in an outpatient neurology clinic suggest the participation of the central nervous system in this type of cluster headache. Expand
Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis.
TLDR
The results suggest that the profile of sumatriptan may differ in cluster headache compared with migraine, and these results must be viewed with caution. Expand
...
1
2
3
4
5
...